American Healthcare REIT Inc. (AHR)
NYSE NYSE Primary 
XDUS 
American Healthcare REIT, Inc. (AHR) Q4 2025 Earnings Call Transcript
American Healthcare REIT, Inc. (AHR) Q4 2025 Earnings Call Transcript
Property Type Round-Up From REITWorld 2025
REITs are positioned for robust growth in 2026, driven by decelerating supply, disciplined capital allocation, and significant valuation discounts to NAV and private markets. Sector preferences favor Healthcare and Data Centers for durable growth, with Shopping Centers and select Residential REITs offering underappreciated upside and private capital interest. Strategic alternatives, buybacks, and targeted M&A are increasingly in focus, especially for deeply discounted names like CSR, WSR, COLD, and REXR.
American Healthcare REIT: A Compelling Growth Story, But Not On My Shopping List
American Healthcare REIT is rated a hold, reaffirming my prior 2 hold ratings. This is contrarian to the bullish consensus of Wall Street and some analysts recently. AHR's strengths come from a growing portfolio and future pipeline, macro demand for senior care and outpatient medical, FFO growth, and modest leverage risk vs. peers. Consider this stock has a limited dividend growth history since 2024 and is trading at a 3x premium to book value, with some technical chart indicators also showing a hold pattern.
5 Dividend Buys That Fill Me With Yuletide Joy
Some end-of-year Big Picture thoughts, including on the demographic destiny of falling population growth and the headwinds to economic growth that come with it. Why tariff-driven inflation is unlikely to generate anything more than a short-term bump followed by continued disinflation. Why the huge amount of cash on the sidelines could progressively become a tailwind to other types of financial assets, including dividend-paying stocks.
Has American Healthcare REIT, Inc. (AHR) Outpaced Other Finance Stocks This Year?
Here is how American Healthcare REIT (AHR) and KeyCorp (KEY) have performed compared to their sector so far this year.
The State Of REITs: December 2025 Edition
The REIT sector returned to positive territory in November (+1.02%) after back-to-back months in the red. Mid caps (+3.53%) led the REIT sector in November followed by small caps (+3.38%) and large caps (+0.32%); micro caps (-8.76%) badly underperformed. 68.15% of REIT securities had a positive total return in November.
Are You Looking for a Top Momentum Pick? Why American Healthcare REIT (AHR) is a Great Choice
Does American Healthcare REIT (AHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Seniors Housing REITs: Generational Compounding Opportunity
Demand tailwinds from the aging Baby Boomer cohort and record-low new construction underpin a multi-year runway for double-digit internal and external growth. Premiums to NAV enable accretive acquisitions, and current valuations underestimate the durability and longevity of the SH cycle for these REITs. VTR, WELL, and AHR are best positioned to benefit from exceptional internal growth combined with robust and accretive external growth.
Are Finance Stocks Lagging American Healthcare REIT, Inc. (AHR) This Year?
Here is how American Healthcare REIT (AHR) and Axis Capital (AXS) have performed compared to their sector so far this year.
Is American Healthcare REIT, Inc. (AHR) Stock Outpacing Its Finance Peers This Year?
Here is how American Healthcare REIT (AHR) and Axis Capital (AXS) have performed compared to their sector so far this year.
American Healthcare REIT (AHR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for American Healthcare REIT (AHR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
American Healthcare REIT (AHR) Tops Q3 FFO and Revenue Estimates
American Healthcare REIT (AHR) came out with quarterly funds from operations (FFO) of $0.44 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to FFO of $0.36 per share a year ago.
